My Cart [ 0 ]
Home > Chemicals > Inhibitors, Activators, Antagonists, and Agonists > A-Z Inhibitors, Activators, Antagonists, and Agonists > GSK461364

GSK461364

Catalog No. Product Name Size List Price (US$) Quantity
APIM050169 GSK461364 10 mg 145.00
APIM050169 GSK461364 50mg 400.00
APIM050169 GSK461364 100 mg 650.00
Description

Background Information:

A highly potent, selective and ATP-competitive inhibitor of polo-like kinase 1 (Ki = 2.2 nM), and is 400-fold greater potency than PLK 2 and 3, currently in clinical trial.

Reference:

1. T.R. Rheault, et al., Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties. Bioorg. Med. Chem. Lett. 2010, 20(15), 4587-92.
2. K.A. Emmitte, et al., Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding. Bioorg. Med. Chem. Lett., 2009, 19(6), 1694-7.

APIM050169: GSK461364

CAS No.: 929095-18-1.
Molecular Formula: C27H28F3N5O2S ? 0.3HCl.
Molecular Weight: 554.5.
Purity: >99% by HPLC, 100% optical purity (Chiral HPLC).
QC: HPLC-MS, 1HNMR, Chiral HPLC, and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO, and water with 2.0 eq. of HCl.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.

 

Related Links

See our Privacy Policy